ConductScience.org, home

Paper9302128

Peyronie's disease is associated with an increase in transforming growth factor-beta protein expression.

El-Sakka AI and 4 others. J Urol, 1997. Cited by 190 papers, by iCite.

Cite this record

ConductScience Library. Peyronie's disease is associated with an increase in transforming growth factor-beta protein expression. Papers, record 9302128. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9302128

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Peyronie's disease is associated with an increase in transforming growth factor-beta protein expression.
PubMed
Journal
J Urol
PubMed
Year
1997
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
190
iCite
Relative citation ratio, by iCite
6.5
iCite
Revised in PubMed
2004-11-17
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1El-Sakka AIA I
2Hassoba HMH M
3Pillarisetty RJR J
4Dahiya RR
5Lue TFT F

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Penile IndurationMajor topic
Transforming Growth Factor betaMajor topic
Humans
Male
Penis

Cited by67

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 190 citations.

PMIDTitleJournalYearIn PapersSource
42125414Peyronie's disease in Spain: a prospective study.Sex Med2026https://conductscience.org/library/papers/42125414PubMed
41777620Contemporary Management Strategies for Peyronie's Disease: A Comprehensive Review.Res Rep Urol2026https://conductscience.org/library/papers/41777620PubMed
40182573Urinary transforming growth factor beta-1 levels correlate with the effect of renorrhaphy on functional outcomes post-laparoscopic partial nephrectomy: A pilot-study.Arab J Urol2025https://conductscience.org/library/papers/40182573PubMed
39807474Effects of therapy in experimental models of Peyronie's disease: a scoping review.Sex Med2024https://conductscience.org/library/papers/39807474PubMed
38454161Unveiling the molecular Hallmarks of Peyronie's disease: a comprehensive narrative review.Int J Impot Res2024https://conductscience.org/library/papers/38454161PubMed
38028732Role of adipose-derived stem cells in healing surgically induced trauma of the rat's tunica albuginea.Sex Med2023https://conductscience.org/library/papers/38028732PubMed
37547872European Society of Sexual Medicine consensus statement on the use of animal models for studying Peyronie's disease.Sex Med2023https://conductscience.org/library/papers/37547872PubMed
37510885Fibrotic Diseases of the Human Urinary and Genital Tract: Current Understanding and Potential Strategies for Treatment.J Clin Med2023https://conductscience.org/library/papers/37510885PubMed
37198341The 100 most-cited publications on Peyronie's disease: a bibliometric analysis and visualization study.Int J Impot Res2024https://conductscience.org/library/papers/37198341PubMed
36782023Characterization of a novel rabbit model of Peyronie's disease.Int J Impot Res2024https://conductscience.org/library/papers/36782023PubMed
35292292Whole-Genome Sequencing Identifies Novel Heterozygous Mutation in ALMS1 in Three Men With Both Peyronie's and Dupuytren's Disease.Urology2022https://conductscience.org/library/papers/35292292PubMed
33879509A nutraceutical strategy for downregulating TGFβ signalling: prospects for prevention of fibrotic disorders, including post-COVID-19 pulmonary fibrosis.Open Heart2021https://conductscience.org/library/papers/33879509PubMed
33243422A Population-Based Study of Peyronie's Disease in Turkey: Prevalence and Related Comorbidities.Sex Med2020https://conductscience.org/library/papers/33243422PubMed
32257868Minimally invasive therapies for Peyronie's disease: the current state of the art.Transl Androl Urol2020https://conductscience.org/library/papers/32257868PubMed
32201669Advances in stem cell therapy for the treatment of Peyronie's disease.Intractable Rare Dis Res2020https://conductscience.org/library/papers/32201669PubMed
31496148Vactosertib, a Novel, Orally Bioavailable Activin Receptor-Like Kinase 5 Inhibitor, Promotes Regression of Fibrotic Plaques in a Rat Model of Peyronie's Disease.World J Mens Health2020https://conductscience.org/library/papers/31496148PubMed
31190155A review of inflammation and fibrosis: implications for the pathogenesis of Peyronie's disease.World J Urol2020https://conductscience.org/library/papers/31190155PubMed
31093703Management of Peyronie's disease with collagenase Clostridium histolyticum in the acute phase.World J Urol2020https://conductscience.org/library/papers/31093703PubMed
29944666Corticosteroid inhibits differentiation of palmar fibromatosis-derived stem cells (FSCs) through downregulation of transforming growth factor-β1 (TGF-β1).PLoS One2018https://conductscience.org/library/papers/29944666PubMed
29706035Silencing Histone Deacetylase 7 Alleviates Transforming Growth Factor-β1-Induced Profibrotic Responses in Fibroblasts Derived from Peyronie's Plaque.World J Mens Health2018https://conductscience.org/library/papers/29706035PubMed

See all 67 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
TGFB17040PubTator's text mininghttps://conductscience.org/library/genes/7040NCBI Gene
TGFB27042PubTator's text mininghttps://conductscience.org/library/genes/7042NCBI Gene
TGFB37043PubTator's text mininghttps://conductscience.org/library/genes/7043NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/9302128

GET https://conductscience.org/api/papers/v1/9302128/cited_by?page=2